• Poster

Estimating the Probability of a Favorable Assessment of Additional Clinical Benefits for a New Drug in Germany Using an MCDA Approach

Citation

Williams, P., Mauskopf, J., Kilburg, A., & Lebiecki, J. (2012, November). Estimating the Probability of a Favorable Assessment of Additional Clinical Benefits for a New Drug in Germany Using an MCDA Approach. Presented at ISPOR 15th Annual European Congress, .

Abstract